• Xiaoying Ji, Jinxiu Li, Li Xu, Wenjing Wang, Ming Luo, Shuangling Luo, Libing Ma, Keng Li, Subo Gong, Long He, Zhijun Zhang, Ping Yang, Zhiguang Zhou, Xudong Xiang, and Cong-Yi Wang.
• Department of Respiratory Medicine, the Second Xiangya Hospital, Central South University, Changsha, China.
• Int J Clin Exp Patho. 2013 Jan 1;6(8):1481-92.

AbstractSevere asthma is a chronic airway disease characterized by the Th2/Th17-polarized inflammation along with permanent airway remodeling. Despite past extensive studies, the exact role for Th2 and Th17 cytokines in asthmatic pathoetiology, particularly in the pathogenesis of bronchial epithelial-mesenchymal transition (EMT), is yet to be fully addressed. We herein conducted studies in 16-HBE cells and demonstrated that Th2-derived IL-4 and Th17-derived IL-17A provide a chronic inflammatory milieu that favors TGF-β1 to induce bronchial EMT. A synergic action was noted between TGF-β1, IL-4 and IL-17A in terms of induction of EMT. IL-4 and IL-17A synergized with TGF-β1 to induce epithelial cells re-entering cell cycle, and to promote epithelial to mesenchymal morphological transistion, and by which they enhanced the capacity of TGF-β1 to suppress E-cadherin expression, and to induce a-SMA expression in epithelial cells. Mechanistic studies revealed that this synergic action is coordinated by the regulation of ERK1/2 activity. Our results not only provide a novel insight into the understanding of the mechanisms underlying airway remodeling in asthmatic condition, but also have the potential for developing more effective therapeutic strategies against severe asthmatics in clinical settings.

37 keywords...

hide…